肾臟病市场规模、份额、成长分析（按类型、适应症、诊断、治疗方法、年龄层和地区划分）－2025-2032年产业预测

全球肾臟病市场预计在 2023 年达到 23 亿美元，从 2024 年的 24.2 亿美元成长到 2032 年的 36 亿美元，在预测期（2025-2032 年）内复合年增长率为 5.1%。

泌尿系统阻塞（例如肾结石、先天性畸形和肿瘤）发生率的上升正显着影响全球肾臟病市场。这些疾病会阻碍尿液流动，导致肾臟肿胀和功能受损，促使患者寻求诊断和治疗方法方案，包括微创技术和外科手术。生活方式的改变、饮食习惯的改变以及人口老化等因素共同推动了全球对先进肾臟病管理解决方案的需求。同时，超音波、 电脑断层扫描和MRI等先进影像技术的广泛应用，使得对肾臟结构进行精确、非侵入性的检查成为可能，从而实现早期诊断和适当干预，减少併发症并改善患者预后。价格合理的影像设备的日益普及也进一步推动了该市场的发展，促进了成长并创造了投资机会。

全球肾臟病市场驱动因素

全球肾臟病市场的主要驱动力是泌尿系统阻塞（例如肾结石、先天性疾病和肿瘤）盛行率的上升。这些疾病会导致储存、肾臟肿大和肾功能受损，增加了对创新诊断技术和高效治疗方法的需求。随着医疗系统努力应对这些挑战，对尖端解决方案的需求持续推动全球市场的扩张。人们对肾臟病管理的认识和关注度不断提高，进一步推动了该细分市场的成长，凸显了及时干预和先进护理策略的重要性。

限制全球肾臟病市场的因素

全球肾臟病市场面临许多限制因素，其中之一是大众对肾臟疾病的认知不足，以及许多开发中国家早期筛检计画的覆盖范围有限。这种认知不足导致诊断延误，进而降低肾臟病治疗的有效性。由于及时发现对于最佳干预至关重要，治疗效果的降低抑制了对先进诊断和治疗方案的需求。因此，这些因素对服务不足地区的市场成长和扩张构成重大挑战，限制了全球肾臟病市场的整体发展。

全球肾臟病市场趋势

全球肾臟病市场正呈现出一个显着的趋势，即越来越重视儿科护理，尤其是在先天性尿路阻塞的治疗方面。人工智慧辅助影像技术和早期筛检方法的进步彻底改变了检测能力，使得对婴幼儿进行及时、准确的干预成为可能。这种对儿科护理的日益重视不仅有助于改善肾臟的长期健康状况，也拓宽了可供选择的专业治疗方案的范围。因此，这一趋势为针对儿科族群的创新诊断和治疗解决方案创造了巨大的市场机会，从而提升了整个肾臟病市场的成长潜力。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球肾臟病市场规模（按类型和复合年增长率划分）（2025-2032 年）

• 市场概览
• 单侧肾臟病
• 双侧肾臟病

全球肾臟病市场规模（按适应症和复合年增长率划分）（2025-2032 年）

• 市场概览
• 内源性
  • 急性单侧阻塞性泌尿道疾病
  • 肾结石
  • 膀胱癌
  • 膀胱结石
  • 尿道狭窄
  • 骨盆器官脱垂
  • 其他内源性指标
• 外源性
  • 腹膜后纤维化
  • 卵巢静脉症候群
  • 其他外源性适应症

全球肾臟病市场规模（按诊断和复合年增长率划分）（2025-2032 年）

• 市场概览
• 实验室测试
  • 尿液检查
  • 血液常规检查
  • 电解质分析
  • 其他测试
• 影像诊断
  • 超音波
  • 静脉肾盂造影
  • KUB X光检查
  • 电脑断层扫描
  • 其他成像方式

全球肾臟病市场规模（按治疗方法和复合年增长率划分）（2025-2032 年）

• 市场概览
• 体外震波碎石术
• 腹腔镜手术
• 膀胱导尿术
• 类固醇疗法
• 其他治疗方法

全球肾臟病市场规模（按年龄组别划分）及复合年增长率（2025-2032 年）

• 市场概览
• 成人
• 孩子们

全球肾臟病市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Fresenius Medical Care AG & Co. KGaA（Germany）
• Baxter International Inc.（USA）
• Boston Scientific Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Johnson & Johnson MedTech（USA）
• Medtronic PLC（Ireland）
• Olympus Corporation（Japan）
• Intuitive Surgical（USA）
• Coloplast A/S（Denmark）
• Teleflex Incorporated（USA）
• Becton, Dickinson and Company（BD）（USA）
• Cook Medical（USA）
• Stryker Corporation（USA）
• KARL STORZ SE & Co. KG（Germany）
• Dornier MedTech（Germany/USA）
• Nipro Corporation（Japan）
• Asahi Kasei Corporation（Japan）
• Cardinal Health（USA）
• Convatec Group PLC（UK）
• Richard Wolf GmbH（Germany）

结论与建议

Global Hydronephrosis Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.42 billion in 2024 to USD 3.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The rising incidence of urinary tract obstructions, such as kidney stones, congenital anomalies, and tumors, is significantly influencing the global hydronephrosis market. These conditions hinder urine flow, leading to kidney swelling and deterioration, which prompts patients to seek diagnostic and therapeutic options, including minimally invasive techniques and surgical interventions. Contributing factors like lifestyle changes, dietary habits, and aging populations are intensifying the demand for advanced hydronephrosis management solutions worldwide. Concurrently, the proliferation of sophisticated imaging technologies, such as ultrasound, CT scans, and MRI, enables precise, non-invasive examination of kidney structures. This permits early diagnosis and appropriate intervention, minimizing complications and enhancing patient outcomes. The accessibility of affordable imaging devices further bolsters this market, driving growth and attracting investment opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hydronephrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hydronephrosis Market Segments Analysis

Global Hydronephrosis Market is segmented by Type, Indication, Diagnosis, Treatment, Age Group and region. Based on Type, the market is segmented into Unilateral hydronephrosis and Bilateral hydronephrosis. Based on Indication, the market is segmented into Intrinsic and Extrinsic. Based on Diagnosis, the market is segmented into Laboratory tests and Imaging. Based on Treatment, the market is segmented into Shock wave lithotripsy, Laparoscopy, Bladder catheterization, Steroid therapy and Other treatment types. Based on Age Group, the market is segmented into Adult and Pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hydronephrosis Market

The global hydronephrosis market is significantly driven by the rising prevalence of urinary tract obstructions such as kidney stones, congenital disorders, and tumors. These medical issues result in urine buildup, kidney enlargement, and compromised renal function, leading to an increased demand for innovative diagnostic technologies and efficient treatment options. As healthcare systems strive to address these challenges, the need for cutting-edge solutions continues to propel market expansion on a global scale. The heightened awareness and focus on managing hydronephrosis further contribute to the growth trajectory of this market segment, emphasizing the importance of timely intervention and advanced care strategies.

Restraints in the Global Hydronephrosis Market

The Global Hydronephrosis market faces significant constraints due to the lack of public awareness regarding kidney disorders in many developing countries, coupled with the limited access to early screening programs. This deficiency in awareness often leads to delayed diagnoses, which in turn undermines the effectiveness of treatments for hydronephrosis. As timely detection is crucial for optimal intervention, the resulting decrease in treatment efficacy restricts the demand for advanced diagnostic and therapeutic options. Consequently, these factors pose considerable challenges to market growth and expansion in these underserved regions, limiting the overall progress of the Hydronephrosis market on a global scale.

Market Trends of the Global Hydronephrosis Market

The Global Hydronephrosis market is witnessing a notable trend towards enhanced pediatric focus, particularly in addressing congenital urinary tract obstructions. Advances in AI-assisted imaging and early screening methodologies are revolutionizing detection capabilities, allowing for timely and accurate interventions in infants and children. This heightened emphasis on pediatric care not only fosters improved long-term kidney health outcomes but also broadens the spectrum of specialized treatment options available. Consequently, this trend is generating significant market opportunities for innovative diagnostic and therapeutic solutions tailored specifically for the pediatric population, elevating the overall growth potential within the hydronephrosis market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hydronephrosis Market Size by Type & CAGR (2025-2032)

• Market Overview
• Unilateral hydronephrosis
• Bilateral hydronephrosis

Global Hydronephrosis Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Intrinsic
  • Acute unilateral obstructive uropathy
  • Kidney stone
  • Bladder cancer
  • Bladder stones
  • Urethral stricture
  • Pelvic organ prolapses
  • Other intrinsic indications
• Extrinsic
  • Retroperitoneal fibrosis
  • Ovarian vein syndrome
  • Other extrinsic indications

Global Hydronephrosis Market Size by Diagnosis & CAGR (2025-2032)

• Market Overview
• Laboratory tests
  • Urinalysis
  • Complete blood count
  • Electrolyte analysis
  • Other laboratory tests
• Imaging
  • Ultrasound
  • Intravenous pyelography
  • KUB X-Rays
  • CT-scan
  • Other imaging types

Global Hydronephrosis Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Shock wave lithotripsy
• Laparoscopy
• Bladder catheterization
• Steroid therapy
• Other treatment types

Global Hydronephrosis Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adult
• Pediatric

Global Hydronephrosis Market Size & CAGR (2025-2032)

• North America (Type, Indication, Diagnosis, Treatment, Age Group)
  • US
  • Canada
• Europe (Type, Indication, Diagnosis, Treatment, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, Diagnosis, Treatment, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, Diagnosis, Treatment, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, Diagnosis, Treatment, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson MedTech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dornier MedTech (Germany/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Richard Wolf GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations